Report Description
Neurotechnology Market Outlook 2031:
The global neurotechnology market size was valued at USD 12.82 Billion in 2022 and is projected to reach USD 34.15 Billion by 2031, expanding at a CAGR of 11.5% during the forecast period 2023 - 2031. The growth of the market is attributed to the increasing prevalence of neurological disorders and continuous advancements in neurotechnology.
Neurotechnology refers to all technologies used to comprehend the brain, visualize its process, and improve its functions. Neurotechnology uses various techniques to record brain activities. It can aid in stimulating some parts of the brain as well. It provides great insight into the brain and nervous system.
Neurotechnology is roughly divided into three categories: neuromodulation technologies, neuroprostheses, and brain-machine interfaces. Neuromodulation technologies use neural interfaces to stimulate the nervous system and influence neural activities. Neuroprostheses work as prosthetic brain functions, which can replace or restore any motor, sensory, and cognitive functions that are lost. Brain-machine interfaces facilitate individuals to external software or hardware.
Market Trends, Drivers, Restraints, and Opportunities
- Growing prevalence of neurological disorders across the globe is expected to drive the global neurotechnology market during the forecast period.
- Continuous advancements in neurotech devices and methods boost the market.
- Rising geriatric population across the globe is estimated to fuel the growth of the market in the coming years.
- Increasing research & development activities in neurotechnology spur the market.
- High costs of neurotechnological products and stringent government regulations are anticipated to restrain the growth of the market during the forecast period.
- Lack of healthcare professionals skilled in neurotechnology hampers the growth of the market.
- Rising demand for neurotech devices to treat obesity offers growth opportunities to the market players.
Scope of the Neurotechnology Market Report
The report on the global neurotechnology market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
Neurotechnology Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2022
|
Historic Data
|
2016–2021
|
Forecast Period
|
2023–2031
|
Segmentation
|
Types (Neurostimulation, Neurological Implants, Imaging Modalities, Cranial Surface Measurement, and Others), and End-users (Diagnostic Centers, Clinics, Hospitals, Ambulatory Surgical Centers, and Others)
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Siemens Healthineers AG; Shimadzu Corporation; General Electric Company; Koninklijke Philips N.V.; Canon Medical Systems Corporation; Toshiba Medical Systems Corporation; Elektra; Tristan Technologies, Inc.; Hitachi Medical Corporation; Natus Medical Incorporated; Magstim; OpenBCI; Allergen Medical Systems Limited; Varjo Technologies Oy; Novela Neurotechnologies, Inc.; and Others
|
Neurotechnology Market Segment Insights
Imaging modalities segment holds a key market share
On the basis of types, the neurotechnology market is segregated into neurostimulation, neurological implants, imaging modalities, cranial surface measurement, and others. The imaging modalities segment accounted for a large market share in 2020, and it is projected to expand at a significant rate during the forecast period. The growing geriatric population and increasing road accidents, where brain imaging is necessary to diagnose injuries, are the key factors driving the imaging modalities.
Hospitals segment expands rapidly
Based on end-users, the market is divided into diagnostic centers, clinics, hospitals, ambulatory surgical centers, and others. The hospital segment is projected to register significant growth during the forecast period, owing to the increasing adoption of neurotechnology or neurotech devices in hospitals for various treatments such as deep brain stimulation.

Asia Pacific dominates the market
In terms of regions, the market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in Asia Pacific is estimated to register a high CAGR during the forecast period, due to rising modernization in the healthcare sector and increasing government initiatives and funding for the advancement of neurotechnology in the region.
The market in North America is anticipated to expand at a significant pace during the forecast period, due to the growing prevalence of neurological disorders in the region. The increasing geriatric population and rising research & development activities in the region boost the market in North America.
Segments
The global neurotechnology market has been segmented on the basis of
Types
- Neurostimulation
- Neurological Implants
- Imaging Modalities
- Cranial Surface Measurement
- Others
End-users
- Diagnostic Centers
- Clinics
- Hospitals
- Ambulatory Surgical Centers
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Siemens Healthineers AG
- Shimadzu Corporation
- General Electric Company
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- Toshiba Medical Systems Corporation
- Elektra
- Tristan Technologies, Inc.
- Hitachi Medical Corporation
- Natus Medical Incorporated
- Magstim
- OpenBCI
- Allergen Medical Systems Limited
- Varjo Technologies Oy
- Novela Neurotechnologies, Inc.
- Others
Competitive Landscape
The global neurotechnology market is competitive with the presence of key players such as Siemens Healthineers AG; Shimadzu Corporation; General Electric Company; Koninklijke Philips N.V.; Canon Medical Systems Corporation; Toshiba Medical Systems Corporation; Elektra; Tristan Technologies, Inc.; Hitachi Medical Corporation; Natus Medical Incorporated; Magstim; OpenBCI; Allergen Medical Systems Limited; Varjo Technologies Oy; Novela Neurotechnologies, Inc.; and others, who use strategies such as mergers, partnerships, acquisitions, collaborations, and product launches to strengthen their hold on the market.
For example, in May 2022, OpenBCI announced a partnership with Varjo Technologies Oy to launch a hardware and software platform, Galea, which simultaneously collects data from the heart, skin, eyes, muscles, and brain of users.
In June 2022, Novela Neurotechnologies, Inc. acquired the complete intellectual property portfolio of Brain Sentinel, Inc., which places the company in a prominent position in epilepsy care.

Table Of Content
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Neurotechnology Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Neurotechnology Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Neurotechnology Market - Supply Chain
4.5. Global Neurotechnology Market Forecast
4.5.1. Neurotechnology Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Neurotechnology Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Neurotechnology Market Absolute $ Opportunity
5. Global Neurotechnology Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Neurotechnology Market Size and Volume Forecast by Types
5.3.1. Neurostimulation
5.3.2.
Neurological Implants
5.3.3.
Imaging Modalities
5.3.4.
Cranial Surface Measurement
5.3.5.
Others
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Neurotechnology Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Neurotechnology Market Size and Volume Forecast by End Users
6.3.1. Diagnostic Centers
6.3.2.
Clinics
6.3.3.
Hospitals
6.3.4.
Ambulatory Surgical Centers
6.3.5.
Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Neurotechnology Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Neurotechnology Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Neurotechnology Demand Share Forecast, 2019-2026
8. North America Neurotechnology Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Neurotechnology Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Neurotechnology Market Size and Volume Forecast by Types
8.4.1. Neurostimulation
8.4.2.
Neurological Implants
8.4.3.
Imaging Modalities
8.4.4.
Cranial Surface Measurement
8.4.5.
Others
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Neurotechnology Market Size and Volume Forecast by End Users
8.7.1. Diagnostic Centers
8.7.2.
Clinics
8.7.3.
Hospitals
8.7.4.
Ambulatory Surgical Centers
8.7.5.
Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Neurotechnology Demand Share Forecast, 2019-2026
9. Latin America Neurotechnology Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Neurotechnology Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Neurotechnology Market Size and Volume Forecast by Types
9.4.1. Neurostimulation
9.4.2.
Neurological Implants
9.4.3.
Imaging Modalities
9.4.4.
Cranial Surface Measurement
9.4.5.
Others
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Neurotechnology Market Size and Volume Forecast by End Users
9.7.1. Diagnostic Centers
9.7.2.
Clinics
9.7.3.
Hospitals
9.7.4.
Ambulatory Surgical Centers
9.7.5.
Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Neurotechnology Demand Share Forecast, 2019-2026
10. Europe Neurotechnology Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Neurotechnology Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Neurotechnology Market Size and Volume Forecast by Types
10.4.1. Neurostimulation
10.4.2.
Neurological Implants
10.4.3.
Imaging Modalities
10.4.4.
Cranial Surface Measurement
10.4.5.
Others
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Neurotechnology Market Size and Volume Forecast by End Users
10.7.1. Diagnostic Centers
10.7.2.
Clinics
10.7.3.
Hospitals
10.7.4.
Ambulatory Surgical Centers
10.7.5.
Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Neurotechnology Demand Share Forecast, 2019-2026
11. Asia Pacific Neurotechnology Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Neurotechnology Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Neurotechnology Market Size and Volume Forecast by Types
11.4.1. Neurostimulation
11.4.2.
Neurological Implants
11.4.3.
Imaging Modalities
11.4.4.
Cranial Surface Measurement
11.4.5.
Others
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Neurotechnology Market Size and Volume Forecast by End Users
11.7.1. Diagnostic Centers
11.7.2.
Clinics
11.7.3.
Hospitals
11.7.4.
Ambulatory Surgical Centers
11.7.5.
Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Neurotechnology Demand Share Forecast, 2019-2026
12. Middle East & Africa Neurotechnology Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Neurotechnology Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Neurotechnology Market Size and Volume Forecast by Types
12.4.1. Neurostimulation
12.4.2.
Neurological Implants
12.4.3.
Imaging Modalities
12.4.4.
Cranial Surface Measurement
12.4.5.
Others
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Neurotechnology Market Size and Volume Forecast by End Users
12.7.1. Diagnostic Centers
12.7.2.
Clinics
12.7.3.
Hospitals
12.7.4.
Ambulatory Surgical Centers
12.7.5.
Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Neurotechnology Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Neurotechnology Market: Market Share Analysis
13.2. Neurotechnology Distributors and Customers
13.3. Neurotechnology Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Siemens Healthineers AG
13.4.2.
Shimadzu Corporation
13.4.3.
General Electric Company
13.4.4.
Koninklijke Philips N.V.
13.4.5.
Canon Medical Systems Corporation
13.4.6.
Toshiba Medical Systems Corporation
13.4.7.
Elektra
13.4.8.
Tristan Technologies, Inc.
13.4.9.
Hitachi Medical Corporation
13.4.10.
Natus Medical Incorporated